SlidesetHIVState of the ART: What’s the same – what’s different – is it clinicially relevant?- Charles Flexner, MDView Slideset
SlidesetHIVManaging drug-drug interactions in patients with multiple co-medications- Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVPView Slideset
SlidesetHIVState of the ART: What’s the same – what’s different – Is it clinicially relevant?- Eric Arts, PhDView Slideset
SlidesetHIVMonitoring and avoiding integrase inhibitor toxicity- Gordon Arbess, MD, CCFPView Slideset
SlidesetHIVReducing HIV associated inflammation – do the drugs matter?- Darrell Tan, BSc, MD, FRCPC, PhDView Slideset
SlidesetHIVImproving care of HIV infected women: What needs to be done?- Sharon Walmsley, FRCPC, MD, MSCView Slideset
SlidesetHIVNovel drug delivery systems: will they have a place in routine HIV clinical care? (Not yet available)- Courtney Fletcher, PharmDView Slideset